INO Inovio Pharmaceuticals, Inc.

NASDAQ
$1.69

Inovio Pharmaceuticals, Inc. (INO) Earnings News

Earnings press releases, previews and reviews for Inovio Pharmaceuticals, Inc. (INO), newest first. Our most recent is review: Inovio Misses on Normalized Loss, but VOCERYQ Approval and $80.5 Million Raise Reset the Story Around Launch Execution.